Xenetic Biosciences, Inc.
XBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534525
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Xenetic Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q4 2022
- Shares held
- 578.0K
- −116.1K (−16.7%) vs. Q4 2022
- Total value
- $235.3K
- +$37.7K (+19.1%) vs. Q4 2022
- New holders
- 2
- 3 more added
- Sold out
- 2
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $442.8K |
| Q1 2026 | 6 | $453.0K |
| Q4 2025 | 11 | $496.6K |
| Q3 2025 | 10 | $183.7K |
| Q2 2025 | 9 | $250.2K |
| Q1 2025 | 13 | $293.1K |
| Q4 2024 | 13 | $356.1K |
| Q3 2024 | 9 | $211.6K |
| Q2 2024 | 5 | $62.0K |
| Q1 2024 | 7 | $73.8K |
| Q4 2023 | 7 | $60.7K |
| Q3 2023 | 7 | $79.4K |
| Q2 2023 | 9 | $120.4K |
| Q1 2023 | 19 | $235.3K |
| Q4 2022 | 19 | $197.6K |
| Q3 2022 | 16 | $535.0K |
| Q2 2022 | 15 | $828.0K |
| Q1 2022 | 14 | $1.07M |
| Q4 2021 | 22 | $1.88M |
| Q3 2021 | 19 | $3.43M |
| Q2 2021 | 14 | $832.2K |
| Q1 2021 | 12 | $1.22M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Xenetic Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 99,507 | $40.0K | 0.00% | −43,893−30.6% | Reduced |
| Vanguard Group Inc | 96,982 | $39.4K | 0.00% | −61,641−38.9% | Reduced |
| Geode Capital Management, LLC | 91,545 | $37.7K | 0.00% | −798−0.9% | Reduced |
| Susquehanna International Group, LLP | 77,819 | $32.1K | 0.00% | +52,779+210.8% | Added |
| HRT Financial LP | 37,473 | $15.0K | 0.00% | −18,992−33.6% | Reduced |
| State Street Corp | 34,668 | $14.3K | 0.00% | 00.0% | Unchanged |
| JTC Employer Solutions Trusteee Ltd | 26,991 | $11.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,224 | $8.21K | 0.00% | +20,224 | New |
| Steward Partners Investment Advisory, LLC | 19,000 | $7.71K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,760 | $7.21K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,366 | $6.74K | 0.00% | −16,202−49.7% | Reduced |
| Ergoteles LLC | 12,773 | $5.26K | 0.00% | −6,053−32.2% | Reduced |
| Tower Research Capital LLC (TRC) | 11,354 | $5.00K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 10,600 | $4.30K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,952 | $1.20K | 0.00% | −3,017−50.5% | Reduced |
| NewSquare Capital LLC | 260 | $106 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 217 | $89 | 0.00% | +199+1,105.6% | Added |
| Wells Fargo & Company | 105 | $43 | 0.00% | +2+1.9% | Added |
| Simplex Trading, LLC | 1,361 | $0 | 0.00% | +1,361 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −39,767−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −300−100.0% | Sold out |